The Texas Pharmaceutical Initiative

  • Twitter
  • Facebook
  • Google+
  • Linkedin

The Texas Pharmaceutical Initiative (TPI) is established by Ch. 2177, TX Government Code. Ch. 2177 was amended by House Bill 4638 (89th Regular Session).

The goal of the Initiative is to provide greater, and more cost-effective access to prescription drugs and essential medical supplies. In developing and implementing recommendations, TPI is focused on savings and access to benefit employees, dependents, and retirees of public higher education systems, members and dependents of the Employees Retirement System of Texas (ERS) and the Teacher Retirement System of Texas (TRS), individuals under the Texas Department of Criminal Justice or Texas Juvenile Justice Department, and individuals served by health and human services programs.

TPI Business Plan

Pursuant to Tex. Gov’t Code Sec. 2177.006 (2023), TPI submitted its business plan to the Governor, Legislature, and the Legislative Budget Board on September 30, 2024. You may utilize the following link to review the Business Plan for Texas Pharmaceutical Initiative (PDF) and the Business Plan for Texas Pharmaceutical initiative Footnotes (PDF) as submitted.

During the 89th Regular Session of the Legislature (2025), Chapter 2177 was amended with the passage of HB 4638, which took effect on September 1, 2025. HB 4368 requires the TPI to submit a revised Business Plan by June 1, 2026. HB 4638 also set TPI’s enabling statute to expire on September 1, 2027.

The Proposed Revised Business Plan is subject to TPI Board review and final approval. The revised version will be posted on this webpage following an Electronic and Information Resources accessibility review.

Members:

  • Mike McKinney, M.D., Chair, Bryan, TX (Term expires February 1, 2029)
  • Goldina Erowele, Pharm.D., Missouri City, TX (Term expires February 1, 2031)
  • Tony Schell, Austin, TX (Term expires February 1, 2027)
  • Randall Wright, Houston, TX (Term expires February 1, 2029)
  • Position #5 TBD (Term expires February 1, 2027)

Advisory Council Members

  • Michael Lopez, Deputy Executive Commissioner, Operations, Medicaid and CHIP Services Division, Texas Health & Human Services
  • Blaise Duran, Director, Group Benefits Program, Employees Retirement System of Texas
  • Katrina Daniel, Chief Health Care Officer, Teacher Retirement System of Texas
  • Laura Chambers, Executive Director, Office of Employee Benefits, The University of Texas System
  • Sheri Meyer, Director, System Benefits Administration, Texas A&M University System

Click HERE to download the full report.